2026 Regular Session

SB 906

Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations

Law

Jurisdiction

West Virginia

Session

2026 Regular Session

Official source

Chamber

Senate

Session

2026 Regular Session

Jurisdiction

West Virginia

Bill overview

This bill proposes to allow West Virginia doctors to legally prescribe crystalline psilocybin, a naturally occurring psychedelic compound, under the guidance of the FDA and DEA. It would amend state law to permit the prescription, distribution, and marketing of psilocybin compositions approved by the FDA and rescheduled by the DEA. The bill also establishes a process for the Board of Pharmacy to recommend substances for scheduling, considering factors like potential for abuse and scientific evidence.

Key provisions

Authorizes the Board of Pharmacy to recommend substances for scheduling based on federal guidelines and FDA/DEA approvals.
Permits the prescription, distribution, and marketing of crystalline psilocybin that meets FDA approval and is rescheduled by the DEA.
Establishes a process for the Board of Pharmacy to add or remove substances from controlled substance schedules.
Requires the Board of Pharmacy to consider factors such as potential for abuse, scientific evidence, and state of knowledge when making scheduling recommendations.
Specifies that the authority to schedule substances does not extend to certain beverages or non-narcotic substances.
Includes a list of substances currently scheduled in Schedule I, including various synthetic cannabinoids and other controlled substances.
Addresses the scheduling of temporary emergency substances, allowing for the scheduling of compounds containing specific substances until further review.
Provides a mechanism for the Board of Pharmacy to recommend rescheduling or deletion of substances already scheduled based on federal action.

Positions across the state

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Legislative history

2026-02-10Senate

Filed for introduction

2026-02-10Senate

To Health and Human Resources

2026-02-10Senate

Introduced in Senate

2026-02-10Senate

To Health and Human Resources

Passage without roll call

The official record shows passage by unanimous consent or voice vote where no roll call was taken. No member-level tally is available for these steps, and the district map does not apply.

3/14/2026HouseVoice vote
Amendment adopted (Voice vote)
No roll-call vote on record for this action.
3/12/2026HouseVoice vote
Committee amendment adopted (Voice vote)
No roll-call vote on record for this action.

Vote map

House districts

Loading map data

0 districts with vote data

Nay

Yea

Floor votes and chamber actions

Recorded roll calls list how each member voted. Unanimous consent or voice vote appears in the official action history without a roll call; no member-level tally is available for those steps.

Passage without roll call

3/14/2026HouseVoice vote
Amendment adopted (Voice vote)
No roll-call vote on record for this action.
3/12/2026HouseVoice vote
Committee amendment adopted (Voice vote)
No roll-call vote on record for this action.

Recorded roll calls

Read the latest version inline or switch to a previous version.

PDFView source

SB 906

Bill overview

Key provisions

Sponsors

Primary sponsor

Positions across the state

Arguments in favor

Arguments opposed

Passage without roll call

Vote map

Floor votes and chamber actions

Passage without roll call

Recorded roll calls

Bill text

Who is affected

Notable changes

Fiscal impact

Positions across the state

Passage without roll call

Vote map

Floor votes and chamber actions

Passage without roll call

Recorded roll calls